Substance / Medication

Risedronate sodium

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Oral risedronate sodium improves bone mineral density in non-ambulatory patients: a randomized, double-blind, placebo controlled trial.
Cohran Valeria, Cassedy Amy, Hawkins Andre et al. · J Pediatr Rehabil Med · 2013
PMID: 23803341RCT
Efficacy and safety of risedronate sodium in treatment of postmenopausal osteoporosis.
Li Yuming, Zhang Zhongzhi, Deng Xiuling et al. · J Huazhong Univ Sci Technolog Med Sci · 2005
PMID: 16463664RCT
RELATIVE BIOAVAILABILITY OF RISEDRONATE SODIUM ADMINISTERED IN SUPERABSORBENT COPOLYMER PARTICLES VERSUS ORAL SOLUTION TO NORMAL HEALTHY RABBITS.
Shahzad Muhammad Khurram, Hussain Tali, Karim Sabiha et al. · Acta Pol Pharm · 2016
PMID: 29638067Observational
Comparative permeability studies with radioactive and nonradioactive risedronate sodium from self-microemulsifying drug delivery system and solution.
Ilem-Ozdemir Derya, Gundogdu Evren, Ekinci Meliha et al. · Drug Dev Ind Pharm · 2015
PMID: 25285358Observational
Bioequivalence study of two risedronate sodium film-coated tablet formulations in healthy volunteers.
Simanjuntak R, Setiawati E, Yunaidi D A et al. · Drug Res (Stuttg) · 2014
PMID: 24002927Observational
In vitro disintegration studies of weekly generic and branded risedronate sodium formulations available in Canada.
Walker A D, Adachi J D · Curr Med Res Opin · 2011
PMID: 21781014Observational
Preparation and evaluation of floating risedronate sodium Gelucire 39/01 matrices.
Chauhan Bhaskar, Shimpi Shyma, Mahadik Kakasaheb et al. · Acta Pharm · 2004
PMID: 15610617Observational
Squamous metaplasia of the conjunctiva: a previously unrecognized adverse effect of risedronate sodium.
Geneva Ivayla I, Eagle Ralph C, Barker-Griffith Ann et al. · JAMA Ophthalmol · 2013
PMID: 23411897Case Report
Mitigating gastrointestinal side effects of risedronate sodium: A study on Bletilla striata polysaccharide microneedle patches.
Wang Cong, Liu Wenting, Huang Yong et al. · Int J Pharm · 2025
PMID: 40288506Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Risedronate sodium (substance)
SNOMED CT
387064005
UMLS CUI
C0166025

Clinical Data

This intervention maps to 2 entities in the Ltrl knowledge graph.

2
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.